Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Operating expenses:
Research and development	$ 26,748	$ 11,213	$ 43,821	$ 21,062
General and administrative	7,041	5,086	14,715	9,445
Total operating expenses	33,789	16,299	58,536	30,507
Loss from operations	(33,789)	(16,299)	(58,536)	(30,507)
Interest income	876	23	1,101	48
Other income (expense), net	(7)	2	(18)
Net loss	$ (32,920)	$ (16,274)	$ (57,453)	$ (30,459)
Net loss per share, basic	$ (0.81)	$ (0.40)	$ (1.41)	$ (0.76)
Net loss per share, diluted	$ (0.81)	$ (0.40)	$ (1.41)	$ (0.76)
Weighted-average shares of common stock used to compute net loss per shares, basic	40,687,751	40,247,110	40,652,224	40,151,802
Weighted-average shares of common stock used to compute net loss per shares, diluted	40,687,751	40,247,110	40,652,224	40,151,802